I now have enough data from the textbooks combined with my comprehensive knowledge of NEET PG microbiology to build the high-yield revision notes. Let me compile everything now.
π§« NEET PG MICROBIOLOGY - HIGH YIELD REVISION NOTES
Target: Under 5000 Rank | Your NEET PG Mentor Guide
HOW TO USE THESE NOTES
- Buzzwords are in bold - these trigger answers in MCQs
- β
β
β
= Must-know (appears every year)
- β
β
= Frequently asked
- β
= Occasional
- PYQ tags indicate previously asked question type
SECTION 1: BACTERIOLOGY
π‘ GRAM-POSITIVE COCCI
STAPHYLOCOCCUS AUREUS β
β
β
Buzzwords: Coagulase +, Catalase +, Protein A, MRSA, Mannitol salt agar, Golden yellow pigment
| Feature | Detail |
|---|
| Gram stain | Gram +ve cocci in clusters (grape-like) |
| Media | Mannitol salt agar (selective), Blood agar (beta-hemolysis) |
| Key enzyme | Coagulase (distinguishes from CoNS) |
| Protein A | Binds Fc of IgG β inhibits opsonization |
| Pigment | Golden yellow (aureus = gold) |
| Catalase | Positive (differentiates from Streptococcus) |
Toxins (HIGH YIELD TABLE):
| Toxin | Disease | Mechanism |
|---|
| Exfoliative toxin (ETA, ETB) | SSSS (Scalded Skin Syndrome) | Serine protease β cleaves desmoglein-1 (epidermis splits) |
| TSST-1 (Toxic Shock Syndrome Toxin) | TSS | Superantigen β massive cytokine release |
| Enterotoxin (A-E, SE) | Food poisoning (rapid onset 2-6 hrs) | Preformed toxin, heat stable, superantigen |
| Panton-Valentine Leukocidin (PVL) | CA-MRSA, necrotizing pneumonia, furunculosis | Pore-forming toxin β leukocyte lysis |
| Alpha toxin | Membrane pore formation, dermonecrosis | β |
Diseases:
- SSSS β Nikolsky sign +ve, infants, cleavage in stratum granulosum (NOT subepidermal like TEN)
- Food poisoning β fastest onset (2-6 hrs), nausea/vomiting without fever, heat-stable toxin (cooking doesn't destroy)
- Endocarditis β IV drug users β tricuspid valve (right-sided), prosthetic valve infections
- Osteomyelitis β MCC in children, hematogenous spread, metaphysis of long bones
- Nasal carrier: anterior nares
Treatment:
- Community MRSA: TMP-SMX, doxycycline, clindamycin, linezolid
- Hospital MRSA: Vancomycin (IV, DOC), alternatives: daptomycin, linezolid, tigecycline
- MSSA: Nafcillin/oxacillin (beta-lactamase resistant penicillins)
- Vancomycin resistance mediated by: VanA gene (acquired from Enterococcus)
PYQ-type: "A neonate develops bullous lesions with Nikolsky sign. Organism?" β S. aureus (exfoliative toxin, SSSS)
"Food poisoning 2 hrs after party meal, no fever?" β S. aureus preformed enterotoxin
STREPTOCOCCUS PYOGENES (Group A Strep) β
β
β
Buzzwords: Beta-hemolysis, Bacitracin sensitive, ASO titer, M protein, PANDAS
| Feature | Detail |
|---|
| Group | Lancefield Group A |
| Hemolysis | Beta-hemolysis |
| Sensitivity | Bacitracin sensitive (PYD test +ve) |
| Key virulence | M protein (antiphagocytic, main virulence factor) |
| Toxin | Streptolysin O (ASO titer) β cardiotoxic; Streptolysin S (oxygen-stable) |
Diseases:
- Pharyngitis β MCC bacterial pharyngitis
- Impetigo β Most common skin infection in children (GAS or S. aureus)
- Scarlet fever β Erythrogenic toxin (pyrogenic exotoxin A/B/C); strawberry tongue, sandpaper rash, Pastia's lines in skin folds
- Rheumatic Fever β Post-strep, Jones criteria, ASO titer elevated; Aschoff bodies (pathognomonic)
- PSGN β Post-strep GN, low complement (C3), nephritic syndrome, anti-DNase B
- Necrotizing fasciitis β Type II (GAS alone)
- PANDAS: Pediatric Autoimmune Neuropsychiatric Disorders
Key distinguishing tests:
- Bacitracin sensitive = Group A (pyogenes)
- Bacitracin resistant = Group B (agalactiae)
- Optochin sensitive = S. pneumoniae
- Bile solubility +ve = S. pneumoniae
PYQ-type: "Pastia lines, strawberry tongue after sore throat?" β Scarlet fever, S. pyogenes
"Jones criteria + ASO titer elevated?" β Rheumatic Fever
STREPTOCOCCUS PNEUMONIAE β
β
β
Buzzwords: Optochin sensitive, Bile soluble, Quellung reaction, Rusty sputum, Diplococci, Quelling
| Feature | Detail |
|---|
| Morphology | Lancet-shaped diplococci (gram +ve) |
| Capsule | Polysaccharide (main virulence factor, antiphagocytic) |
| Test | Optochin sensitive, Bile soluble |
| Special test | Quellung reaction (capsular swelling with specific antibody) |
Diseases:
- Lobar pneumonia β rusty/prune juice sputum, MCC in adults
- Meningitis β MCC in adults, elderly; Indian ink stain NOT done here (that's for Cryptococcus)
- Otitis media β MCC
- Sinusitis β MCC
- Septicemia β especially in asplenic patients (OPSI - Overwhelming Post-Splenectomy Infection)
Vaccine: PCV13 (conjugate, T-cell dependent) / PPSV23 (polysaccharide, T-cell independent)
Resistance: PBP2x mutation β penicillin resistance
Treatment: Penicillin (sensitive strains); Ceftriaxone + Vancomycin for meningitis
PYQ-type: "Most common cause of lobar pneumonia?" β S. pneumoniae
"Asplenic patient with sepsis?" β S. pneumoniae (encapsulated bacteria)
STREPTOCOCCUS AGALACTIAE (Group B) β
β
Buzzwords: CAMP test, Neonatal meningitis, Neonatal sepsis, Group B
- Neonatal sepsis + meningitis (MCC in neonates along with E. coli)
- CAMP test +ve (arrowhead hemolysis with S. aureus)
- Bacitracin resistant
- Screening: vaginal swab at 35-37 weeks pregnancy
- Treatment: Ampicillin (intrapartum prophylaxis)
ENTEROCOCCUS β
β
Buzzwords: PYP test, NaCl tolerance, UTI hospital, VRE
- Grows in 6.5% NaCl and bile (PYP test +ve)
- MCC of hospital-acquired UTI (with E. coli as community)
- VRE (Vancomycin-Resistant Enterococcus) β VanA gene β transferred vancomycin resistance to MRSA
- Treatment of VRE: Linezolid, daptomycin, tigecycline
π΅ GRAM-NEGATIVE COCCI
NEISSERIA MENINGITIDIS β
β
β
Buzzwords: Waterhouse-Friderichsen, Meningococcemia, petechiae, chocolate agar, oxidase +ve
| Feature | Detail |
|---|
| Media | Chocolate agar, Thayer-Martin medium |
| Oxidase | Positive |
| Capsule | Polysaccharide (serogroups A, B, C, W, Y, X) |
| Carrier site | Nasopharynx |
| Fermentation | Ferments glucose AND maltose (key: maltose differentiates from N. gonorrhoeae) |
Diseases:
- Meningitis β MCC in young adults (college students); serogroup B (most common in developed countries), A (sub-Saharan Africa)
- Meningococcemia β petechial/purpuric rash, DIC, shock
- Waterhouse-Friderichsen syndrome β bilateral adrenal hemorrhage, fulminant septicemia
- Complement deficiency (C5-C9) β recurrent Neisseria infections
PYQ-type: "College student with neck stiffness, petechial rash, bilateral adrenal hemorrhage?" β N. meningitidis, Waterhouse-Friderichsen
NEISSERIA GONORRHOEAE β
β
β
Buzzwords: STI, oxidase +ve, chocolate agar, intracellular diplococci, Thayer-Martin, PID
| Feature | Detail |
|---|
| Key | No polysaccharide capsule (no herd immunity from vaccine until recently) |
| Pili | Main virulence factor |
| Fermentation | Glucose only (NOT maltose - key differentiator from N. meningitidis) |
| Media | Thayer-Martin (modified chocolate agar + vancomycin, colistin, nystatin) |
Diseases:
- Urethritis β gram -ve intracellular diplococci in PMNs
- PID β salpingitis, Fitz-Hugh-Curtis syndrome (perihepatitis, violin-string adhesions)
- Ophthalmia neonatorum β MCC bacterial conjunctivitis in newborns (within 24-48 hrs)
- Septic arthritis β MCC in sexually active young adults (disseminated gonococcal infection)
- Arthritis-dermatitis syndrome β migratory polyarthritis, tenosynovitis, vesiculopustular skin lesions
Treatment:
- Uncomplicated: Ceftriaxone 500 mg IM single dose (+ Doxycycline if chlamydia not excluded)
- Ophthalmia neonatorum prophylaxis: Erythromycin eye ointment (or silver nitrate historically - CredΓ©'s method)
PYQ-type: "STI patient with intracellular gram-negative diplococci in PMNs?" β N. gonorrhoeae
"Newborn conjunctivitis day 1-4?" β Gonorrhea (chemical - silver nitrate, day 5+ Chlamydia)
π’ GRAM-POSITIVE RODS
CLOSTRIDIUM TETANI β
β
β
Buzzwords: Drumstick/tennis racquet spore, Tetanospasmin, GABA block, Trismus, Lockjaw
| Feature | Detail |
|---|
| Morphology | Drumstick/tennis racquet spore (terminal spore) |
| Toxin | Tetanospasmin (tetanus toxin) = TeNT |
| Mechanism | Blocks GABA and glycine release at Renshaw cells β spastic paralysis |
| Retrograde transport | Toxin travels via peripheral nerves to CNS |
Diseases:
- Generalized tetanus β Trismus (lockjaw), risus sardonicus, opisthotonus, spasms
- Neonatal tetanus β contaminated umbilical cord stump
- Local tetanus β confined to area of wound
- Cephalic tetanus β CN involvement, trismus + facial palsy
Characteristic: C. tetani does NOT invade tissue - produces toxin locally
Treatment: Wound debridement + TIG (Tetanus Immunoglobulin) + Metronidazole + Diazepam (muscle relaxant) + Active immunization
PYQ-type: "Spastic paralysis after wound, blocks GABA, drumstick spore?" β C. tetani
CLOSTRIDIUM BOTULINUM β
β
β
Buzzwords: Botulin, Flaccid paralysis, Honey infant, ACh block, Presynaptic
| Feature | Detail |
|---|
| Toxin | Botulinum toxin (most potent known toxin) |
| Mechanism | Blocks ACh release at NMJ (presynaptic) β flaccid paralysis |
| Types | A, B, E, F cause human disease; Type A most common food-borne |
| Route | Cleaves SNARE proteins (SNAP-25, VAMP, syntaxin) |
Forms:
- Food-borne β home-canned foods, preserved meats
- Infant botulism β honey ingestion (<1 yr), floppy baby, constipation, MCC of sudden unexpected death in infancy (SUDI) (honey)
- Wound botulism β IV drug users, black tar heroin
- Iatrogenic β cosmetic (Botox, Type A)
Triad: Descending flaccid paralysis + no fever + intact sensorium
Diagnosis: Mouse bioassay (gold standard) - serum, stool
Treatment: Antitoxin (trivalent ABE) + supportive; Infant botulism: Human BIG (Baby BIG) = Botulism Immune Globulin
PYQ-type: "Infant with flaccid paralysis after honey exposure, constipation, descending?" β Infant botulism
"Blocks ACh presynaptically vs tetanus (blocks GABA)?" β Classic PYQ comparison
CLOSTRIDIUM PERFRINGENS β
β
β
Buzzwords: Alpha toxin (lecithinase), Gas gangrene, Double zone hemolysis, Nagler test
| Feature | Detail |
|---|
| Type | Type A β gas gangrene, food poisoning |
| Key toxin | Alpha toxin = Lecithinase (phospholipase C) β main virulence |
| Test | Nagler test (alpha toxin on egg yolk agar β opacity inhibited by antitoxin) |
| Hemolysis | Double zone of hemolysis on blood agar |
| Spore | Subterminal spore |
Diseases:
- Gas gangrene (Clostridial myonecrosis) β crepitant wound, gas in tissues (X-ray), rapid progression
- Food poisoning β Type A, enterotoxin, 8-24 hrs onset, watery diarrhea, no vomiting (unlike S. aureus)
- Necrotizing enterocolitis (Type C, beta toxin)
PYQ-type: "Lecithinase, double zone, gas in wound?" β C. perfringens
CLOSTRIDIUM DIFFICILE β
β
β
Buzzwords: Pseudomembranous colitis, Antibiotic-associated diarrhea, Toxin A+B, Rifaximin, Vancomycin oral
| Feature | Detail |
|---|
| Toxin A | Enterotoxin (diarrhea, fluid secretion) |
| Toxin B | Cytotoxin (cell death, more potent, gold standard detection) |
| Binary toxin | CDT toxin in hypervirulent NAP1/B1/027 strain |
| Trigger | Clindamycin (historically), also fluoroquinolones, cephalosporins, ampicillin |
Diagnosis:
- GDH antigen (screening) + Toxin A/B EIA (confirmation)
- Cell cytotoxicity assay (gold standard for toxin B)
- Stool culture (slow, not routine)
- Colonoscopy: Yellowish pseudomembranes
Treatment:
- Mild-moderate: Oral Vancomycin or Fidaxomicin (DOC, least recurrence)
- Severe: Vancomycin PO + Metronidazole IV
- Fecal Microbiota Transplant (FMT) β recurrent CDI (highly effective)
- Bezlotoxumab (anti-Toxin B monoclonal antibody) β prevention of recurrence
PYQ-type: "Diarrhea after clindamycin therapy, pseudomembranes on colonoscopy?" β C. difficile PMC
BACILLUS ANTHRACIS β
β
β
Buzzwords: Bamboo stick/Medusa head colony, Bioterrorism, Anthrax, Antiphagocytic capsule (D-glutamate)
| Feature | Detail |
|---|
| Capsule | Poly-D-glutamic acid (unusual - only bacterium with amino acid capsule) |
| Toxin | EF (Edema Factor) + PA (Protective Antigen) = Edema toxin; LF (Lethal Factor) + PA = Lethal toxin |
| Colony | Bamboo stick / Medusa head (non-hemolytic, non-motile) |
| Spore | Central spore |
Forms:
- Cutaneous anthrax (most common 95%) β malignant pustule β black eschar (painless)
- Inhalational/Woolsorter's disease β widened mediastinum on CXR (mediastinal hemorrhagic lymphadenitis)
- GI anthrax β contaminated meat
- Anthrax meningitis β hemorrhagic meningitis
Treatment: Ciprofloxacin or Doxycycline; Post-exposure prophylaxis same
Vaccine: AVA (Anthrax Vaccine Adsorbed), protective antigen-based
PYQ-type: "Painless black eschar after animal hide exposure?" β Cutaneous anthrax
"Widened mediastinum + bioterrorism?" β Inhalation anthrax
CORYNEBACTERIUM DIPHTHERIAE β
β
β
Buzzwords: Diphtheria toxin, ADP-ribosylation, EF-2, Metachromatic granules, Bull-neck, Pseudomembrane
| Feature | Detail |
|---|
| Morphology | Chinese letter / V/L shaped arrangement, metachromatic granules (Babes-Ernst bodies) |
| Stain | Albert's stain (granules appear green/blue-black), Neisser's stain |
| Media | Loeffler's serum slope (growth in 6-8 hrs) + Tellurite agar (black colonies) |
| Toxin mechanism | ADP-ribosylation of EF-2 (elongation factor 2) β inhibits protein synthesis |
| Toxin gene | Beta-prophage (tox gene) β lysogenic conversion |
Diseases:
- Pharyngeal diphtheria β gray/white pseudomembrane (bleeds on removal), bull-neck (cervical lymphadenopathy + edema), stridor
- Myocarditis β most common cause of death (cardiac complications)
- Neuropathy β demyelinating; palatal palsy (earliest), accommodation palsy (ciliary muscle), late peripheral neuropathy
- Cutaneous diphtheria β C. ulcerans (zoonotic, same toxin)
Schick test: Tests immunity (not diagnosis) - historical
Treatment: Diphtheria Antitoxin (DAT) (most important, given urgently) + Erythromycin or Penicillin
PYQ-type: "ADP ribosylation of EF-2, grey membrane, bull neck?" β C. diphtheriae
"Toxin of diphtheria encoded by?" β Beta-bacteriophage (lysogenic conversion)
LISTERIA MONOCYTOGENES β
β
β
Buzzwords: Cold enrichment, Tumbling motility, Unpasteurized cheese, Neonatal meningitis, Actin rockets
| Feature | Detail |
|---|
| Motility | Tumbling motility at 25Β°C; Actin rocket motility intracellularly |
| Growth | Cold enrichment (grows at 4Β°C - refrigerator!) |
| Hemolysis | Beta-hemolysis on blood agar |
| CAMP test | Positive (synergistic hemolysis with S. aureus, opposite quadrant to Group B Strep) |
At risk populations:
- Neonates (MCC of neonatal meningitis with Group B Strep, also E. coli)
- Pregnant women β granulomatosis infantiseptica (stillbirth, granulomas)
- Elderly, immunocompromised
- Foodborne: unpasteurized dairy, deli meats, coleslaw
Treatment: Ampicillin (DOC); Note: naturally resistant to cephalosporins
PYQ-type: "Neonatal meningitis + cold enrichment + tumbling motility?" β Listeria monocytogenes
π΄ GRAM-NEGATIVE RODS (ENTEROBACTERIACEAE)
ESCHERICHIA COLI β
β
β
Buzzwords: UTI MCC, Traveler's diarrhea, ETEC, EHEC O157:H7, HUS, Lac+, MacConkey
| Pathotype | Disease | Key Feature |
|---|
| ETEC | Traveler's diarrhea | ST (heat-stable, cGMP) + LT (heat-labile, cAMP, like cholera) |
| EPEC | Infant diarrhea | Attaching-effacing lesions, no toxin, no invasion |
| EHEC (O157:H7) | HUS (Hemolytic Uremic Syndrome) | Shiga-like toxin, bloody diarrhea, NO antibiotics |
| EIEC | Dysentery-like | Invades colon (like Shigella) |
| EAEC | Persistent diarrhea | Biofilm, "stacked brick" pattern |
UTI: MCC of community-acquired UTI
Neonatal meningitis: K1 capsular antigen (cross-reacts with group B meningococcus)
MacConkey agar: Pink colonies (lac+)
HUS triad: Microangiopathic hemolytic anemia + Thrombocytopenia + Acute renal failure
Avoid antibiotics in EHEC (SLT release increases β worse HUS)
PYQ-type: "Bloody diarrhea + renal failure in child after undercooked beef?" β EHEC O157:H7, HUS
"Traveler's diarrhea, rice water-like, cAMP mechanism?" β ETEC
SALMONELLA β
β
β
Buzzwords: Typhoid, Rose spots, Widal test, H2S +ve, Non-lac, Intracellular, Bone marrow culture
| Species | Disease |
|---|
| S. typhi | Typhoid fever |
| S. paratyphi A,B,C | Paratyphoid |
| S. typhimurium/enteritidis | Gastroenteritis (non-typhoidal) |
Typhoid fever:
- 1st week: Bacteremia β blood culture (most sensitive in 1st week)
- 2nd week: Widal test positive (O and H antibodies), Rose spots (faint pink macules, anterior abdomen), constipation (then diarrhea)
- 3rd week: Complications: intestinal perforation + hemorrhage (Peyer's patches)
- 4th week: Resolution or relapse
Widal test: O antibodies (somatic) + H antibodies (flagellar); >1:160 significant (not diagnostic alone)
Best culture: Bone marrow culture (most sensitive throughout disease; 80-90%)
Carrier: Gallbladder (bile = carrier site); treated with ciprofloxacin
Treatment: Ceftriaxone (DOC parenteral), Azithromycin (outpatient/oral), ciprofloxacin (resistance common)
Vaccine: Ty21a (live oral), Vi capsular polysaccharide (inject), Vi-TT conjugate (Typbar-TCV) - latest, preferred in children
PYQ-type: "Relative bradycardia, rose spots, step-ladder fever?" β Typhoid
"Best culture in 1st week of typhoid?" β Blood culture
"Best culture overall in typhoid?" β Bone marrow
SHIGELLA β
β
β
Buzzwords: Dysentery, No H2S, No motility, No lactose, Shiga toxin, Smallest ID, Low inoculum
| Feature | Detail |
|---|
| Motility | Non-motile |
| H2S | Negative (key difference from Salmonella) |
| Inoculum | Lowest infectious dose (~10-100 organisms) |
| Toxin | Shiga toxin (S. dysenteriae type 1) = same as SLT of EHEC |
| Spread | Feco-oral, person-to-person |
Species (4 serogroups):
- S. dysenteriae (Group A) - most severe, Shiga toxin
- S. flexneri (Group B) - MCC in India/developing countries
- S. boydii (Group C)
- S. sonnei (Group D) - MCC in developed countries, mildest
Disease: Bacillary dysentery β crampy pain, tenesmus, blood + mucus in stool, fever
Complications: HUS (Shiga toxin), Reiter's syndrome, toxic megacolon
Treatment: Azithromycin (DOC in children), ciprofloxacin (adults); important - DO treat (unlike EHEC)
PYQ-type: "Smallest infectious dose, bloody diarrhea, non-motile gram-negative rod?" β Shigella
VIBRIO CHOLERAE β
β
β
Buzzwords: Rice water stool, El Tor, O1/O139, CTX phage, cAMP, TCBS, Comma-shaped
| Feature | Detail |
|---|
| Morphology | Comma-shaped (vibrio), darting motility |
| Media | TCBS (Thiosulfate Citrate Bile Salt Sucrose agar) β yellow colonies (V. cholerae, sucrose +ve) |
| Toxin mechanism | CT (cholera toxin) β ADP ribosylates GsΞ± β βcAMP β βCl- secretion |
| Toxin gene | CTXΟ (filamentous bacteriophage) β lysogenic conversion |
| Virulence cluster | VPI-1 (Vibrio Pathogenicity Island) β TCP pilus |
| Serogroup | O1 (El Tor biotype - current pandemic) + O139 (Bengal) |
Disease:
- Profuse watery "rice water" diarrhea (no blood, no pus = secretory diarrhea)
- Severe dehydration β "washerwoman's hands," "sunken eyes"
- No invasion, no inflammation
El Tor vs Classical: El Tor (milder, carrier state more common, current 7th pandemic)
O139: First non-O1 to cause epidemic cholera, no cross-immunity with O1
Treatment: Oral Rehydration Therapy (ORT) = cornerstone; Antibiotics: Doxycycline (single dose, adults), tetracycline; reduces duration
PYQ-type: "Rice water stools, ADP ribosylates GsΞ±, cAMP increase?" β V. cholerae
"Yellow colonies on TCBS, O1 El Tor?" β V. cholerae
HELICOBACTER PYLORI β
β
β
Buzzwords: Urease +ve (most), CLO test, Bismuth, Triple therapy, PUD, MALT lymphoma, Gastric cancer
| Feature | Detail |
|---|
| Morphology | Spiral-shaped (helical), gram-negative |
| Urease | Strongly urease +ve (most clinically relevant feature) |
| Media | Skirrow's medium (selective), microaerophilic conditions |
| Tests | CLO test (rapid urease test on biopsy), UBT (Urea Breath Test) (non-invasive, best for follow-up), Stool antigen (non-invasive), Serology |
Associations:
- Peptic ulcer disease (90% duodenal, 70% gastric)
- MALT lymphoma (H. pylori eradication can cure early MALT lymphoma!)
- Gastric adenocarcinoma (WHO Group 1 carcinogen)
- Non-ulcer dyspepsia
Treatment (Triple therapy): PPI + Clarithromycin + Amoxicillin x 14 days
Quadruple therapy: PPI + Bismuth + Metronidazole + Tetracycline (resistance)
PYQ-type: "MALT lymphoma cured by antibiotics?" β H. pylori eradication
"Non-invasive test of choice to confirm eradication?" β Urea Breath Test (UBT)
π€ MYCOBACTERIA
MYCOBACTERIUM TUBERCULOSIS β
β
β
Buzzwords: AFB, Ziehl-Neelsen, Lowenstein-Jensen, Ghon focus, Caseous necrosis, Cord factor, PPD/Mantoux
| Feature | Detail |
|---|
| Stain | Ziehl-Neelsen β red bacilli on blue background (acid-fast = retain carbol fuchsin) |
| Fluorescent | Auramine-rhodamine (more sensitive screening) |
| Media | Lowenstein-Jensen (LJ) medium β buff/cream colonies, 6-8 weeks |
| BACTEC | Liquid culture (faster, 9-14 days) |
| Cell wall | Mycolic acids (high lipid content β acid-fastness, slow growth, resistance) |
Key virulence factors:
- Cord factor (trehalose 6,6-dimycolate) β serpentine cording in vitro, inhibits phagosome-lysosome fusion
- Sulfatides β inhibit phagolysosome fusion
- LAM (Lipoarabinomannan) β inhibits macrophage activation
Pathogenesis:
- Ghon focus = primary focus in lung (lower lobe of upper / upper lobe of lower)
- Ghon complex = Ghon focus + regional lymph nodes
- Simon focus = hematogenous seeding of apex (later reactivation site)
- Ranke complex = calcified Ghon complex + lymph nodes
Tuberculin test (Mantoux/PPD):
- 0.1 mL 5TU PPD intradermally
- Read at 48-72 hours
- β₯10 mm = positive (general); β₯5 mm in HIV/immunocompromised/close contact; β₯15 mm in low-risk individuals
- False positive: BCG, NTM (non-tuberculous mycobacteria)
- False negative: Miliary TB, severe malnutrition, HIV, sarcoidosis, measles
IGRA (Interferon Gamma Release Assay): QuantiFERON-TB Gold; Not affected by BCG; Preferred in BCG-vaccinated
Treatment (standard):
- 2HRZE + 4HR (2 months Isoniazid + Rifampicin + Pyrazinamide + Ethambutol, then 4 months HR)
- INH + Rifampicin = most bactericidal combination (sterilizing activity)
- Pyrazinamide = sterilizing activity (kills semi-dormant bacilli)
- Ethambutol = prevents resistance (visual side effect β optic neuritis)
Side effects (HIGH YIELD):
| Drug | Key Side Effect |
|---|
| Isoniazid (INH) | Peripheral neuropathy (B6 deficiency) β give pyridoxine; hepatotoxicity; drug-induced lupus |
| Rifampicin | Orange discoloration of body fluids; Hepatotoxicity; potent CYP450 inducer β OCP failure |
| Pyrazinamide | Hyperuricemia (gout); hepatotoxicity |
| Ethambutol | Retrobulbar optic neuritis β color vision (red-green) loss, visual acuity loss |
| Streptomycin | Ototoxicity (vestibular > cochlear), nephrotoxicity |
PYQ-type: "TB drug causing peripheral neuropathy?" β INH (pyridoxine deficiency)
"Drug causing red-green color blindness?" β Ethambutol
"Drug contraindicated in pregnancy?" β Streptomycin (ototoxic to fetus)
"Rifampicin + OCP?" β Decreased OCP efficacy (CYP inducer)
MYCOBACTERIUM LEPRAE β
β
β
Buzzwords: Cannot culture, Armadillo, Globi, Fite-Faraco, Leonine facies, Lucio phenomenon
| Feature | Detail |
|---|
| Culture | Cannot be cultured in vitro (grows in mouse footpad, armadillo) |
| Stain | Fite-Faraco stain (modified ZN) |
| Appearance | Globi (bundles of bacilli in macrophages = lepra cells/Virchow cells) |
| Temperature | Grows best at 27-30Β°C (cool extremities) |
Types:
| Type | Immunity | Bacilli | Lepromin | Features |
|---|
| Tuberculoid (TT) | High CMI | Few (paucibacillary) | +ve | Hypopigmented anesthetic patches, nerve thickening |
| Lepromatous (LL) | Low CMI | Many (multibacillary) | -ve | Leonine facies, madarosis, orchitis, Virchow cells, glove-stocking anesthesia |
| Borderline (BL/BT/BB) | Variable | Variable | Variable | Unstable, reactions common |
Lepromin test (Mitsuda test): Tests cellular immunity (NOT diagnosis)
- Fernandez reaction (48 hrs) = type IV hypersensitivity
- Mitsuda reaction (28 days) = granuloma formation
Complications:
- Type 1 reaction (Reversal) β Borderline forms, sudden upgrading
- Type 2 reaction (ENL - Erythema Nodosum Leprosum) β Lepromatous, immune complex (type III), treat with Thalidomide
- Lucio phenomenon β severe necrotizing vasculitis in Lucio leprosy (diffuse LL)
Treatment (MDT - Multi Drug Therapy):
- PB (Paucibacillary): Dapsone + Rifampicin x 6 months
- MB (Multibacillary): Dapsone + Rifampicin + Clofazimine x 12 months
PYQ-type: "Lepromin +ve, paucibacillary, anesthetic patch?" β Tuberculoid leprosy
"ENL reaction in leprosy treated by?" β Thalidomide
π OTHER IMPORTANT BACTERIA
HAEMOPHILUS INFLUENZAE β
β
β
Buzzwords: Chocolate agar, X+V factor, Satellite phenomenon, Polysaccharide capsule type b, Epiglottitis
| Feature | Detail |
|---|
| Growth factors | X factor (hemin) + V factor (NAD) - both required for H. influenzae |
| Media | Chocolate agar (releases X+V factors); Levinthal's agar (for capsule typing) |
| Satellite phenomenon | Grows around S. aureus streak on blood agar (S. aureus provides V factor) |
Diseases:
- Epiglottitis β type b strain; "cherry red epiglottis," thumbprint sign on lateral neck X-ray, high fever, drooling, stridor; DO NOT examine throat (can cause complete obstruction)
- Meningitis β was MCC in children <5 yrs (now rare post-Hib vaccine)
- Otitis media, sinusitis β non-typeable strains (MCC overall in adults)
- Cellulitis β "brawny" blue-red cellulitis on face/head in young children
Vaccine: Hib vaccine (conjugate polysaccharide, T-cell dependent) β dramatically reduced type b disease
PYQ-type: "Thumbprint sign on lateral neck X-ray, child with drooling?" β Epiglottitis, H. influenzae type b
BORDETELLA PERTUSSIS β
β
β
Buzzwords: Whooping cough, 100-day cough, Bordet-Gengou agar, Filamentous hemagglutinin, Lymphocytosis
| Feature | Detail |
|---|
| Media | Bordet-Gengou agar (potato blood glycerol agar) β mercury droplet / bisected pearl colonies |
| Key toxin | Pertussis toxin (PT) β ADP-ribosylates Gi (inhibitory G-protein) β βcAMP |
| Other toxins | Filamentous hemagglutinin (FHA) (main adhesin), Tracheal cytotoxin, Adenylate cyclase toxin |
Disease stages:
- Catarrhal stage (1-2 weeks) β like common cold, most infectious
- Paroxysmal stage (2-6 weeks) β inspiratory whoop, posttussive vomiting, lymphocytosis (absolute)
- Convalescent β gradual recovery
Complications: Pneumonia (MCC death), encephalopathy, subconjunctival hemorrhage, inguinal hernia
Treatment: Azithromycin (DOC); macrolides erythromycin (contraindicated in infants <1 month β pyloric stenosis)
PYQ-type: "Absolute lymphocytosis + paroxysmal cough + whoop?" β Pertussis
"Mercury droplet colony morphology?" β Bordetella pertussis
PSEUDOMONAS AERUGINOSA β
β
β
Buzzwords: Grape-like odor, Blue-green pigment, Burn patients, CF, Hot tub folliculitis, Meropenem
| Feature | Detail |
|---|
| Pigments | Pyocyanin (blue-green), Pyoverdin/fluorescein (yellow-green, fluorescent) |
| Odor | Grape-like / fruity (2-aminoacetophenone) |
| Media | MacConkey (non-lac fermenter, colorless colonies) |
| Resistance | Intrinsic resistance to many antibiotics; biofilm formation |
Diseases:
- Burns β most dangerous nosocomial pathogen in burns
- Cystic fibrosis β mucoid strains (alginate overproduction), chronic colonization
- Nosocomial pneumonia (VAP - ventilator-associated)
- Otitis externa ("Swimmer's ear"), Malignant otitis externa (diabetics, elderly)
- Hot tub folliculitis (serotype O:11)
- Ecthyma gangrenosum β black necrotic skin lesion in immunocompromised (bacteremia)
Treatment: Anti-pseudomonal beta-lactam (piperacillin-tazobactam, ceftazidime, cefepime, meropenem) + Aminoglycoside or fluoroquinolone (ciprofloxacin)
PYQ-type: "Blue-green pus in burn wound, grape-like odor?" β Pseudomonas aeruginosa
"Ecthyma gangrenosum in neutropenic patient?" β P. aeruginosa bacteremia
SECTION 2: VIROLOGY
HIV β
β
β
Buzzwords: CD4, CXCR4/CCR5, Reverse transcriptase, p24, ELISA+Western blot, Window period, ART
| Feature | Detail |
|---|
| Family | Retroviridae (lentivirus) |
| Genome | ssRNA (+sense), diploid (2 copies) |
| Envelope | gp120 (attachment to CD4), gp41 (fusion) |
| Key enzyme | Reverse transcriptase (RNAβDNA), Integrase, Protease |
| Co-receptors | CXCR4 (T-tropic, X4 strains) + CCR5 (M-tropic, R5 strains); CCR5 Ξ32 mutation β resistance to HIV |
Window period: 3-12 weeks (ELISA becomes positive)
4th generation ELISA: Detects both p24 antigen + antibody β reduces window period
HIV staging (CD4 count):
- >500/mmΒ³ β asymptomatic
- 200-500 β early symptoms, constitutional
- <200 β AIDS-defining (PCP, MAI, CMV, Cryptococcus, Toxoplasma)
- <50 β CMV retinitis, MAC disseminated
AIDS-defining illnesses (IMPORTANT):
- PCP (Pneumocystis jirovecii) β CD4 <200, GGO on HRCT, LDH elevated, BAL diagnosis, TMP-SMX treatment
- CMV retinitis β CD4 <50, "pizza pie" / "cheese and ketchup" retina, Ganciclovir
- Toxoplasma encephalitis β CD4 <100, ring-enhancing lesions, Pyrimethamine + Sulfadiazine
- Cryptococcal meningitis β CD4 <100, India ink +ve, latex agglutination (capsular antigen = most sensitive), Amphotericin B + Flucytosine
- MAC (Mycobacterium avium complex) β CD4 <50, disseminated, Azithromycin (prophylaxis), Clarithromycin + Ethambutol + Rifabutin (treatment)
ART drugs (KEY side effects):
| Drug | Side Effect |
|---|
| Tenofovir (TDF) | Nephrotoxicity, Fanconi syndrome, decreased bone density |
| Zidovudine (AZT) | Anemia, neutropenia, myopathy; mitochondrial toxicity |
| Abacavir (ABC) | Hypersensitivity reaction (HLA-B*5701 screening) |
| Efavirenz | Neuropsychiatric (vivid dreams, dizziness), avoid in pregnancy (1st trimester) |
| Nevirapine | Stevens-Johnson syndrome, hepatotoxicity |
| Lopinavir/Ritonavir | GI intolerance, lipodystrophy, QT prolongation |
| Raltegravir (Integrase inhibitor) | CPK elevation, rhabdomyolysis |
| Maraviroc (CCR5 antagonist) | Hepatotoxicity, test CCR5 tropism first |
PYQ-type: "CD4 <200 + GGO on HRCT?" β PCP
"Ring-enhancing brain lesion in HIV patient?" β Toxoplasmosis (multiple); Primary CNS lymphoma (solitary/single in later stages)
HEPATITIS VIRUSES β
β
β
Buzzwords: HAV feco-oral, HBV ssDNA, HCV MCC chronic, HDV superinfection, HEV pregnant
| Virus | Family | Genome | Route | Chronicity |
|---|
| HAV | Picornavirus | +ssRNA | Feco-oral | Never chronic |
| HBV | Hepadnavirus | Partially dsDNA (unique) | Parenteral/sexual/vertical | 5-10% adults, 90% neonates |
| HCV | Flavivirus | +ssRNA | Parenteral | 70-80% (highest chronicity) |
| HDV | Deltavirus | -ssRNA (circular, virusoid) | Parenteral (needs HBV) | Co-infection <5%, superinfection >70% |
| HEV | Hepevirus | +ssRNA | Feco-oral | Highest mortality in pregnancy (20-30%) |
HBV Serology (CRITICAL TABLE):
| Marker | Significance |
|---|
| HBsAg | Acute/chronic infection marker |
| Anti-HBs | Immunity (vaccine-induced OR recovery) |
| HBeAg | Active viral replication, high infectivity |
| Anti-HBe | Low infectivity (except pre-core mutant!) |
| Anti-HBc IgM | Acute HBV (also positive in window period!) |
| Anti-HBc IgG | Past infection or chronic infection |
| Window period | HBsAg -ve, Anti-HBs -ve, Anti-HBc IgM +ve |
| Core window | Anti-HBc is the ONLY positive marker |
Pre-core mutant: HBeAg -ve but HBV DNA +ve (cannot make HBeAg but still replicates)
HCV treatment: Direct Acting Antivirals (DAAs) - Sofosbuvir + Ledipasvir/Daclatasvir; >95% SVR
PYQ-type: "HBsAg -ve, Anti-HBs -ve, Anti-HBc IgM +ve?" β Window period of HBV
"Hepatitis with highest mortality in pregnancy?" β HEV
"Hepatitis that never becomes chronic?" β HAV
HERPES VIRUSES β
β
β
Buzzwords: Latency, dsDNA, Multinucleated giant cells, Tzanck smear, Acyclovir
| Virus | Disease | Latency Site |
|---|
| HSV-1 | Oral herpes, encephalitis (temporal lobe), keratoconjunctivitis | Trigeminal ganglion |
| HSV-2 | Genital herpes, neonatal herpes | Sacral ganglion |
| VZV | Chickenpox, Shingles (herpes zoster) | Dorsal root ganglion |
| EBV | Infectious mononucleosis, Burkitt's lymphoma, NPC, Hodgkin's lymphoma | B-lymphocytes |
| CMV | Congenital CMV (MCC congenital viral infection), retinitis in HIV, mono-like in immunocompetent | Monocytes/macrophages |
| HHV-6 | Roseola infantum (exanthem subitum), 6th disease | T-lymphocytes |
| HHV-7 | Roseola (some cases) | T-lymphocytes |
| HHV-8 | Kaposi's sarcoma, PEL (primary effusion lymphoma) | B-lymphocytes/endothelial |
EBV/Mono:
- Monospot test = Paul-Bunnell test (heterophile antibodies, IgM)
- Atypical lymphocytes (Downey cells)
- Complications: Splenic rupture, airway obstruction, meningoencephalitis
- Avoid ampicillin β causes maculopapular rash in EBV
- Associated tumors: Burkitt's lymphoma (t(8;14), c-myc), NPC (nasopharyngeal carcinoma), Hodgkin's lymphoma
CMV congenital:
- Periventricular calcifications (vs Toxo = diffuse calcifications)
- Sensorineural hearing loss (MCC of congenital SNHL), chorioretinitis, microcephaly
PYQ-type: "Atypical lymphocytes, splenomegaly, positive monospot, avoid ampicillin?" β EBV mono
"Periventricular calcifications in TORCH infection?" β CMV (vs toxo = diffuse/basal ganglia)
INFLUENZA VIRUS β
β
β
Buzzwords: H and N antigens, Antigenic shift vs drift, Amantadine, Oseltamivir, Reassortment
| Feature | Detail |
|---|
| Family | Orthomyxovirus |
| Genome | Segmented -ssRNA (8 segments for A & B) |
| Antigens | HA (Hemagglutinin) = attachment (fusion); NA (Neuraminidase) = release from cells |
| Antigenic drift | Point mutations in HA/NA β minor changes β seasonal epidemics |
| Antigenic shift | Reassortment of gene segments between different strains β major change β pandemics |
Pandemic 2009 (H1N1): Reassortment of human + swine + avian strains
Influenza A - causes pandemics (most important); infects humans, birds, pigs, horses
Influenza B - only humans, milder, no pandemics
Influenza C - no NA, mild upper respiratory
Treatment: Oseltamivir (Tamiflu) - neuraminidase inhibitor; start within 48 hrs
Amantadine/Rimantadine - M2 protein blockers, only Influenza A, high resistance now
Complications: Pneumonia (primary viral or secondary bacterial S. aureus/Strep pneumo), Reye's syndrome (aspirin in children - AVOID), encephalitis
PYQ-type: "Pandemic influenza caused by?" β Antigenic shift (reassortment)
"Mechanism of action of Oseltamivir?" β Neuraminidase inhibitor
RABIES VIRUS β
β
β
Buzzwords: Negri bodies, Hydrophobia, Rhabdovirus, Post-exposure prophylaxis, Bullet-shaped
| Feature | Detail |
|---|
| Family | Rhabdovirus |
| Morphology | Bullet-shaped (bacilliform) |
| Pathology | Negri bodies = eosinophilic cytoplasmic inclusions in Purkinje cells (cerebellum) and hippocampus (Ammon's horn) |
| Spread | Retrograde axonal transport to CNS |
Post-exposure prophylaxis (PEP):
- Category I (touching, licking intact skin) β Wash + No vaccine
- Category II (nibbling, superficial scratch, no bleeding) β Wound wash + Vaccine only
- Category III (transdermal bite, exposure to mucous membrane/saliva) β Wound wash + Vaccine + RIG (Rabies Immunoglobulin)
RIG: Human RIG (HRIG) or Equine RIG (ERIG) β infiltrate at wound site + IM at distant site (if remaining volume)
Vaccine schedule: Days 0, 3, 7, 14, 28 (Essen) OR Days 0, 7, 21/28 (Zagreb 2-1-1)
Diagnosis of animal: Direct fluorescent antibody test (DFA) on brain tissue (gold standard)
PYQ-type: "Negri bodies in hippocampus/Purkinje cells?" β Rabies
"Category III animal bite - management?" β Wound wash + Vaccine + RIG
SECTION 3: PARASITOLOGY
PLASMODIUM (MALARIA) β
β
β
Buzzwords: Anopheles, Schuffner's dots, Quartan/Tertian fever, Blackwater fever, Primaquine liver stage
| Species | Fever Cycle | RBC preference | Special features |
|---|
| P. vivax | Tertian (48 hrs) | Young/reticulocytes (enlarged) | Schuffner's dots, relapse (hypnozoites) |
| P. ovale | Tertian (48 hrs) | Young (enlarged, oval, fimbriated) | Relapse (hypnozoites), Schuffner's dots |
| P. malariae | Quartan (72 hrs) | Old/senescent (normal size) | Band/basket form trophozoites, "rosette" schizonts |
| P. falciparum | Malignant tertian (36-48 hrs) | All ages (most severe) | Maurer's clefts, ring forms only in peripheral blood, no enlargement |
P. falciparum complications:
- Cerebral malaria β ring hemorrhages, DΓΌrck's granuloma
- Blackwater fever β massive hemolysis β hemoglobinuria β dark urine β AKI
- Hyperparasitemia (>5% RBCs parasitized)
- Sequestration (rosetting + cytoadherence) β microvascular obstruction
- ARDS, hypoglycemia (quinine β insulin release)
Diagnosis:
- Thick blood smear = most sensitive (gold standard for low parasitemia)
- Thin blood smear = species identification
- RDT (rapid diagnostic test) = pLDH/HRP-2 antigens
- QBC (Quantitative Buffy Coat) = acridine orange
Treatment:
- Uncomplicated P. vivax/ovale: Chloroquine + Primaquine (for liver hypnozoites - prevent relapse; check G6PD first)
- Uncomplicated P. falciparum: ACT (Artemisinin-based Combination Therapy) - Artemether-Lumefantrine (AL), Artesunate-Mefloquine
- Severe malaria: IV Artesunate (DOC), or IV Quinine + Doxycycline
- Primaquine: NEVER in G6PD deficiency or pregnancy
PYQ-type: "Quartan fever, band forms, rosette?" β P. malariae
"Blackwater fever + hemoglobinuria?" β P. falciparum
"Why give primaquine in P. vivax?" β Eradicate liver hypnozoites (radical cure)
ENTAMOEBA HISTOLYTICA β
β
β
Buzzwords: Flask-shaped ulcer, RBC in trophozoite, Liver abscess anchovy sauce, Metronidazole
| Feature | Detail |
|---|
| Key | RBC in trophozoite (PATHOGNOMONIC of E. histolytica vs E. dispar) |
| Ulcer | Flask-shaped (bottle-neck) ulcer in colon (undermined edges) |
| Liver abscess | Anchovy paste/chocolate sauce pus (= lysed blood + necrotic material, sterile) |
| Cyst | 4 nuclei (mature), chromatoid bars with blunt ends |
| Serology | ELISA for anti-amoebic antibody (liver abscess) |
Amoebic vs Pyogenic liver abscess:
- Amoebic: Young male, single abscess (right lobe), "anchovy paste" pus, sterile, ELISA +ve β Treat with Metronidazole alone (no drainage usually needed)
- Pyogenic: Elderly, multiple abscesses, pus culture +ve (E. coli, Klebsiella) β Antibiotics + drainage
Treatment: Metronidazole (tissue amoebicide) + Diloxanide furoate (luminal amoebicide, for cyst passers/after Metronidazole)
PYQ-type: "Trophozoite with ingested RBCs?" β E. histolytica
"Sterile pus in liver abscess, right lobe, young male?" β Amoebic liver abscess
GIARDIA LAMBLIA β
β
β
Buzzwords: Falling leaf motility, Sucking disc, Steatorrhea, Duodenal aspirate, Metronidazole
- Trophozoite: Pear-shaped, bilateral symmetry (owl/ghost face), 2 nuclei, sucking disc (ventral)
- Cyst: Oval, 4 nuclei
- Motility: Falling leaf motility
- Causes: Malabsorption/steatorrhea (flattening of villi, NOT invading)
- Diagnosis: Stool microscopy (cysts), string test (Entero-test) for trophozoites, ELISA stool antigen
- Treatment: Metronidazole or Tinidazole
TOXOPLASMA GONDII β
β
β
Buzzwords: Definitive host = cat, Congenital toxo, Intracranial calcifications, Sabin-Feldman dye test, Pyrimethamine
- Definitive host: Cat (only host where sexual cycle occurs)
- Transmission: Undercooked meat (tissue cysts), cat feces (oocysts), vertical (congenital)
- Congenital tetrad (Sabin's tetrad): Hydrocephalus + Chorioretinitis + Intracranial calcifications (diffuse, periventricular) + Psychomotor retardation
- AIDS: CD4 <100, ring-enhancing brain lesions (toxoplasma encephalitis)
- Diagnosis: Serology (IgM/IgG), Sabin-Feldman dye test (gold standard - but not done routinely), PCR
- Treatment: Pyrimethamine + Sulfadiazine + Folinic acid (leucovorin)
vs CMV calcifications: Toxo = diffuse/basal ganglia, CMV = periventricular
LEISHMANIASIS β
β
β
Buzzwords: Sandfly Phlebotomus, Aldehyde test, Splenomegaly, Amastigote, Napier's test
| Type | Organism | Feature |
|---|
| Visceral (Kala-azar) | L. donovani | Splenomegaly > hepatomegaly, pancytopenia, hypergammaglobulinemia, blackening of skin |
| Cutaneous | L. tropica, L. major | Painless ulcer, Delhi boil |
| Mucocutaneous | L. braziliensis | Espundia, nose/mouth destruction |
| PKDL | L. donovani | Post-kala-azar dermal leishmaniasis (after treatment) |
Tests:
- Aldehyde test (Napier's formol gel test) β hypergammaglobulinemia β gelatin in formalin within 2 min = +ve (kala-azar)
- Direct agglutination test (DAT) β sensitive and specific
- rK39 dipstick β rapid field test (best for VL)
- Bone marrow/spleen/LN aspirate β definitive (Leishman-Donovan bodies = amastigotes in macrophages)
Treatment: Liposomal Amphotericin B (DOC, India); Miltefosine (oral), Sodium stibogluconate (pentavalent antimony)
SECTION 4: MYCOLOGY
CANDIDA β
β
β
Buzzwords: Pseudohyphae, Germ tube, Azoles, Thrush, Vaginal candidiasis, IELTS
| Feature | Detail |
|---|
| Key test | Germ tube test = C. albicans (forms germ tubes in serum at 37Β°C within 2-3 hrs) |
| Morphology | Pseudohyphae + budding yeast cells |
| Chromogenic agar | Green colonies = C. albicans |
Diseases: Oral thrush (HIV/immunosuppressed/infants), vulvovaginal candidiasis, esophageal candidiasis (AIDS-defining), candidemia (IVDA, TPN, broad-spectrum antibiotics), UTI (catheterized)
Treatment: Fluconazole (oral/systemic, azole); Caspofungin (echinocandin, for Candida resistant to azoles); Nystatin (topical/oral thrush)
CRYPTOCOCCUS NEOFORMANS β
β
β
Buzzwords: India ink, Latex agglutination, Mucoid capsule, Pigeon droppings, CD4 <100
| Feature | Detail |
|---|
| Stain | India ink β clear halo (capsule appears as clear zone) |
| Test | Latex agglutination (capsular polysaccharide antigen = most sensitive, DOC for diagnosis) |
| Source | Pigeon droppings, soil |
| Capsule | Polysaccharide (main virulence) |
Disease: Meningitis in HIV (CD4 <100), "soap bubble lesions" (gelatinous pseudocysts) in brain
Treatment: Amphotericin B + Flucytosine (induction, 2 wks) β Fluconazole (consolidation + maintenance)
CSF findings: Elevated opening pressure, lymphocytosis, decreased glucose, increased protein
ASPERGILLUS FUMIGATUS β
β
β
Buzzwords: Septate hyphae, Dichotomous branching 45Β°, Fruiting head, Voriconazole, Galactomannan
| Feature | Detail |
|---|
| Hyphae | Septate, branching at 45Β° (acute angle) |
| Fruiting head | Conidiophores with vesicle + phialides (sterigmata) |
| Aspergilloma | Fungus ball in pre-existing cavity (TB, sarcoid) β Monod sign (crescent/air-crescent sign on CT) |
Diseases:
- ABPA (Allergic bronchopulmonary aspergillosis) β Asthma + eosinophilia + central bronchiectasis + high IgE; Rx: Prednisolone + Itraconazole
- Invasive aspergillosis β neutropenic patients (AML on chemotherapy), "Halo sign" (early) then "Air-crescent sign" (late) on CT chest; Voriconazole (DOC)
- Aspergilloma β Hemoptysis, no treatment usually (unless hemoptysis), surgical if massive
Diagnosis: Galactomannan assay (serum/BAL) β screens for invasive aspergillosis; Beta-D-glucan (non-specific fungal marker)
PYQ-type: "Halo sign on CT chest in neutropenic patient?" β Invasive aspergillosis
"Aspirin-shaped septate hyphae at 45Β°?" β Aspergillus
MUCOR/RHIZOPUS (MUCORMYCOSIS) β
β
β
Buzzwords: Rhinocerebral, Diabetic ketoacidosis, Non-septate hyphae, 90Β° branching, Black eschar, Liposomal AmphoB
| Feature | Detail |
|---|
| Hyphae | Non-septate (aseptate/coenocytic), branching at 90Β° (right angle) |
| Risk | DKA (most classic), neutropenia, iron overload (deferoxamine!), burns |
| Spread | Angioinvasive β thrombosis, infarction, tissue necrosis |
Forms:
- Rhinocerebral (most common overall) β DKA β black necrotic tissue in nose/palate/orbit β can spread to brain
- Pulmonary β neutropenic patients (similar to Aspergillus)
- GI β malnourished
- Cutaneous β burns
Treatment: Liposomal Amphotericin B (DOC) + surgical debridement + control of underlying disease
Deferoxamine paradox: Deferoxamine (iron chelator) provides iron to Mucor via ferrioxamine β INCREASES risk of mucormycosis
PYQ-type: "DKA patient with black nasal eschar, right-angle branching non-septate hyphae?" β Mucormycosis
"Iron chelation therapy increasing risk of fungal infection?" β Deferoxamine + Mucormycosis
SECTION 5: IMMUNOLOGY (MICROBIOLOGY COMPONENT)
HYPERSENSITIVITY REACTIONS β
β
β
Buzzwords: Gell-Coombs classification, Immediate, Cytotoxic, Immune complex, Delayed
| Type | Mechanism | Mediator | Examples |
|---|
| Type I (Immediate) | IgE + Mast cell degranulation | Histamine, leukotrienes | Anaphylaxis, asthma, urticaria, food allergy |
| Type II (Cytotoxic) | IgG/IgM + complement β cell lysis | Complement, ADCC | Autoimmune hemolytic anemia, Goodpasture's, myasthenia gravis, Graves', transfusion reactions |
| Type III (Immune complex) | IgG immune complex deposition | Complement, neutrophils | SLE, PSGN, serum sickness, Farmer's lung, Arthus reaction |
| Type IV (Delayed/DTH) | T-cell mediated (CD4/CD8) | Cytokines (IL-2, IFN-Ξ³), CTL | TB (PPD test), contact dermatitis, graft rejection |
Serum sickness: Day 7-14, immune complexes, type III; fever + rash + arthralgia + lymphadenopathy
Arthus reaction: Local type III (intradermal antigen in sensitized individual)
PRIMARY IMMUNODEFICIENCIES β
β
β
| Disease | Defect | Key Features |
|---|
| Bruton's X-linked agammaglobulinemia | BTK gene β no B cells, no Ig | Male, >6 months (maternal Ab wanes), recurrent bacterial infections (encapsulated), no tonsils |
| DiGeorge syndrome | 22q11.2 deletion, thymus aplasia β no T cells | Cardiac defects (conotruncal), hypocalcemia (tetany), recurrent viral/fungal infections |
| SCID | Both B + T cell defects (ADA deficiency most common) | Profound infections with all pathogens, graft-vs-host from maternal lymphocytes |
| Hyper-IgM syndrome | CD40L/CD40 defect β no class switching | Very high IgM, no IgG/A/E, Pneumocystis, Cryptosporidium |
| CVID | Late onset, β all Ig | Adults, recurrent bacterial infections, Giardia |
| Chediak-Higashi | LYST gene β giant granules, defective lysosome trafficking | Partial albinism, recurrent infections, giant granules in neutrophils |
| Chronic Granulomatous Disease (CGD) | NADPH oxidase defect β no oxidative burst | Recurrent catalase-positive organisms (S. aureus, Aspergillus, Nocardia, Serratia, Burkholderia), granuloma formation |
| C5-C9 deficiency | Terminal complement defect | Recurrent Neisseria (meningitidis + gonorrhoeae) infections |
| IgA deficiency | Most common primary immunodeficiency | Recurrent sinopulmonary infections, anaphylaxis with blood products (anti-IgA antibodies) |
SECTION 6: HIGH-YIELD MNEMONICS & QUICK RECALL
BUZZWORD-DISEASE QUICK TABLE β
β
β
| Buzzword | Organism | Disease |
|---|
| Drumstick spore | C. tetani | Tetanus |
| Bamboo stick colony | B. anthracis | Anthrax |
| Chinese letter arrangement | C. diphtheriae | Diphtheria |
| Darting motility, rice water | V. cholerae | Cholera |
| Falling leaf motility | Giardia | Giardiasis |
| Negri bodies (Purkinje/hippocampus) | Rabies virus | Rabies |
| Germ tube in serum | C. albicans | Candidiasis |
| India ink halo | Cryptococcus | Cryptococcal meningitis |
| Non-septate hyphae 90Β° | Mucor/Rhizopus | Mucormycosis |
| Septate hyphae 45Β° | Aspergillus | Aspergillosis |
| Ziehl-Neelsen red bacilli | M. tuberculosis | Tuberculosis |
| Fite-Faraco stain | M. leprae | Leprosy |
| Leishman-Donovan bodies | Leishmania | Kala-azar |
| Schuffner's dots | P. vivax/ovale | Malaria |
| Maurer's clefts | P. falciparum | Falciparum malaria |
| RBCs ingested by trophozoite | E. histolytica | Amoebiasis |
| Owl-eye inclusion | CMV | CMV infection |
| Councilman bodies | Yellow fever | Yellow fever |
| Guarnieri bodies | Vaccinia/Smallpox | Poxvirus |
| Downey cells | EBV | Infectious mono |
| Warthin-Finkeldey cells | Measles | Measles |
| Cowdry type A inclusions | HSV/VZV | Herpetic infections |
MEDIA CHEAT SHEET β
β
β
| Medium | Organism(s) |
|---|
| Chocolate agar | N. meningitidis, N. gonorrhoeae, H. influenzae |
| Thayer-Martin | N. gonorrhoeae (selective) |
| Mannitol salt agar | S. aureus (selective) |
| Bordet-Gengou | B. pertussis |
| TCBS (yellow colonies) | V. cholerae |
| TCBS (green colonies) | V. parahaemolyticus |
| Lowenstein-Jensen | M. tuberculosis |
| Skirrow's | H. pylori, Campylobacter |
| BCYE (Buffered Charcoal Yeast Extract) | Legionella pneumophila |
| Tellurite agar | C. diphtheriae (black colonies) |
| MacConkey (pink = lac+) | E. coli, Klebsiella |
| MacConkey (colorless = lac-) | Salmonella, Shigella, Pseudomonas |
| Charcoal blood agar (CBA) | Bordetella pertussis (alternative) |
| Sabouraud's agar | Fungi (most) |
EXOTOXIN vs ENDOTOXIN β
β
β
| Feature | Exotoxin | Endotoxin (LPS) |
|---|
| Source | Gram +ve AND -ve | Gram -ve (outer membrane) |
| Chemistry | Protein | Lipid A (active component) |
| Heat | Labile (mostly) | Heat stable |
| Antigenicity | High (toxoid possible) | Low |
| Lethal dose | Very low | High |
| Superantigen | Some (TSST-1, SPE) | No |
ANTIBIOTICS HIGH YIELD
Beta-lactams mechanism: Inhibit PBPs β block transpeptidation β cell wall synthesis failure β bactericidal
Vancomycin: Inhibits transglycosylation (binds D-Ala-D-Ala precursor)
Aminoglycosides: 30S ribosome β misreading of mRNA β bactericidal; nephrotoxic + ototoxic
Macrolides: 50S ribosome β inhibit translocation β bacteriostatic
Tetracyclines: 30S β block aminoacyl-tRNA binding β bacteriostatic
Chloramphenicol: 50S β inhibit peptidyl transferase β Grey baby syndrome (no glucuronyl transferase in neonates)
Fluoroquinolones: Inhibit DNA gyrase (gram -ve) + Topoisomerase IV (gram +ve)
Rifampicin: Inhibits DNA-dependent RNA polymerase β bactericidal
Metronidazole: Anaerobes + protozoa β free radicals β DNA damage
"30S = ATCM" mnemonic: Aminoglycosides, Tetracyclines, Chloramphenicol (actually 50S), Macrolides
π STUDY STRATEGY FOR MICROBIOLOGY (NEET PG <5000 Rank)
Priority topics (highest yield, based on exam trends):
- Bacterial toxins - mechanism, disease, treatment (appears in every exam)
- HIV/AIDS - staging, OIs, ART side effects
- Tuberculosis - drugs, side effects, diagnosis
- Serology (HBV markers, Widal, VDRL) - interpret scenarios
- Media and stains - simple but reliable marks
- Malaria - species differentiation, complications, drugs
- Immunodeficiencies - match defect to organism
- Antifungals - mechanism and spectrum
Revision technique:
- For each organism: Organism β Unique feature β Disease β Investigation β Treatment
- Use the trigger word (buzzword) tables for rapid MCQ solving
- Practice: "If question says X β think Y organism"
- Revise this sheet 3 times minimum before exam
Sources: Medical Microbiology 9e (Murray), Jawetz Melnick & Adelbergs Medical Microbiology 28e, Sherris & Ryan's Medical Microbiology 8e, Robbins Pathology, Harrison's Internal Medicine 22e
This covers the core of NEET PG Microbiology. Next subjects ready to cover: Pathology, Pharmacology, Physiology, Biochemistry, Anatomy, Surgery, Medicine, OBG, Pediatrics, Ophthalmology, ENT, Orthopedics, Psychiatry, Skin, Radiology, Anesthesia, Forensic Medicine, Community Medicine, Microbiology Done β
Type "next" or name the subject and I'll build the next high-yield revision sheet!